Suvretta Capital Management, LLC Sutro Biopharma, Inc. Transaction History

Suvretta Capital Management, LLC

$3.33 Billion
Q3 2025

A detailed history of Suvretta Capital Management, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 6,488,324 shares of STRO stock, worth $6.16 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,488,324

Previous 6,488,324 -0.0%

Holding current value

$6.16 Million

Previous $4.61 Million 23.95%

% of portfolio

0.17%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.52 - $1.3 $506,568 - $1.27 Million	-974,171 Reduced 13.05%	6,488,324 $4.61 Million
Q4 2024 Feb 14, 2025	BUY	$1.82 - $4.4 $500,500 - $1.21 Million	275,000 Added 3.83%	7,462,495 $13.7 Million
Q3 2024 Nov 14, 2024	SELL	$2.88 - $5.01 $1.5 Million - $2.61 Million	-521,195 Reduced 6.76%	7,187,495 $24.9 Million
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.33 $5.64 Million - $10.3 Million	1,930,502 Added 33.41%	7,708,690 $22.6 Million
Q4 2023 Feb 14, 2024	SELL	$2.07 - $4.54 $218,395 - $478,992	-105,505 Reduced 1.79%	5,778,188 $24.8 Million

Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $827,079 - $1.14 Million	194,607 Added 3.42%	5,883,693 $27.4 Million
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $555,461 - $1.05 Million	123,987 Added 2.23%	5,689,086 $26.3 Million
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $2.95 Million - $4.4 Million	545,099 Added 10.86%	5,565,099 $45 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $1.94 Million - $2.67 Million	375,000 Added 8.07%	5,020,000 $27.9 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $3.11 Million - $8.17 Million	912,600 Added 24.45%	4,645,000 $24.2 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $10.1 Million - $19.8 Million	1,294,605 Added 53.11%	3,732,400 $30.7 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $2.91 Million - $4.8 Million	204,100 Added 9.14%	2,437,795 $36.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $8.75 Million - $11.6 Million	518,314 Added 30.22%	2,233,695 $42.2 Million
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $7.76 Million - $10.3 Million	430,405 Added 33.5%	1,715,381 $31.9 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $5.06 Million - $6.87 Million	249,567 Added 24.1%	1,284,976 $29.2 Million
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $1.37 Million - $3.23 Million	-134,757 Reduced 11.52%	1,035,409 $22.5 Million
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $1.99 Million - $3.52 Million	267,366 Added 29.62%	1,170,166 $11.8 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $5.95 Million - $9.08 Million	821,800 Added 1014.57%	902,800 $7.01 Million
Q1 2020 May 15, 2020	BUY	$6.19 - $12.16 $501,390 - $984,960	81,000 New	81,000 $826,000

Others Institutions Holding STRO

# of Institutions

Shares Held

57.3M

Call Options Held

75K

Put Options Held

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $49.6M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Account

Suvretta Capital Management, LLC Sutro Biopharma, Inc. Transaction History